3B BlackBio Dx Schedules Board Meeting for Q2 Results
3B BlackBio Dx Ltd 路 Intimation 路 13 Nov 2026, 5:30 am
3B BlackBio Dx Schedules Board Meeting for Q2 Results 3B BlackBio Dx Ltd. has scheduled its Board of Directors meeting on 13th Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. In accordance with SEBI insider trading regulations, the trading window for designated persons and their immediate relatives has been closed since 1st Oct'26 and will reopen 48 hours after the declaration of financial results.
Original exchange filing (PDF)
More announcements from 3B BlackBio Dx Ltd
- Analyst/Investor Meet intimation 路 16 Nov 2026
- Financial Results for the quarter and half year ended 30th September, 2026 路 13 Nov 2026
- Financial Results for the quarter and half year ended 30th September, 2026 路 13 Nov 2026
- Investor Presentation 路 13 Nov 2026
- Financial Results for the quarter and half-year ended 30th September, 2026 路 13 Nov 2026
- Outcome of Board Meeting 路 13 Nov 2026
- Re-appointment of director who retires by rotation and being eligible, offers for re-appointment 路 30 Sept 2026
- Scrutinizer''s Report and Voting report for 54th AGM 路 30 Sept 2026
